<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM359477"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">1</item><item key="NO. OF METASTASES">44</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359478"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">15</item><item key="NO. OF METASTASES">10</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359479"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">95</item><item key="NO. OF METASTASES">18</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359480"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">12</item><item key="NO. OF METASTASES">4</item><item key="GENDER">f</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM35948"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">38</item><item key="NO. OF METASTASES">3</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM35948"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">38</item><item key="NO. OF METASTASES">3</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359483"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">10</item><item key="NO. OF METASTASES">16</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359484"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">2</item><item key="NO. OF METASTASES">24</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359485"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">9</item><item key="NO. OF METASTASES">1</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359486"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">31</item><item key="NO. OF METASTASES">3</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359487"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">1</item><item key="NO. OF METASTASES">24</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359488"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">1</item><item key="NO. OF METASTASES">37</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359489"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">60</item><item key="NO. OF METASTASES">1</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359490"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">156</item><item key="NO. OF METASTASES">6</item><item key="GENDER">f</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM35949"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">90</item><item key="NO. OF METASTASES">8</item><item key="GENDER">f</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM35949"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">90</item><item key="NO. OF METASTASES">8</item><item key="GENDER">f</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359493"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">8</item><item key="NO. OF METASTASES">&gt;80</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359494"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">114</item><item key="NO. OF METASTASES">2</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359495"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">11</item><item key="NO. OF METASTASES">2</item><item key="GENDER">f</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM359496"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">not specified</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">not specified</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">127</item><item key="NO. OF METASTASES">5</item><item key="GENDER">m</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559577"><item key="TUMOR STAGE (UICC 2002)">pT1b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 106 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lymph node, bone, adrenal gland</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559578"><item key="TUMOR STAGE (UICC 2002)">pT1b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M1</item><item key="DFS/FOLLOW-UP">DFS = 0 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lung, liver</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559579"><item key="TUMOR STAGE (UICC 2002)">pT1b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 83 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">lung, soft tissue</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559580"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 6 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">lung, adrenal gland, renal</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM55958"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 60 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">bone</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559582"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">Follow-up = 155 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">none</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559583"><item key="TUMOR STAGE (UICC 2002)">pT1a</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 0 months</item><item key="LYMPH NODE STATUS">N2</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lymph node</item><item key="TUMOR GRADE">G3</item></item></item><item><item key="GSM559584"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">Follow-up = 99 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">none</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559585"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 45 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">lung, bone, adrenal gland</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559586"><item key="TUMOR STAGE (UICC 2002)">pT1b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">Follow-up = 112 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">none</item><item key="TUMOR GRADE">G3</item></item></item><item><item key="GSM559587"><item key="TUMOR STAGE (UICC 2002)">pT1a</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 63 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">lung</item><item key="TUMOR GRADE">G3</item></item></item><item><item key="GSM559588"><item key="TUMOR STAGE (UICC 2002)">pT3b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">Follow-up = 143 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">none</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559589"><item key="TUMOR STAGE (UICC 2002)">pT1a</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 96 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lymph node, lung</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559590"><item key="TUMOR STAGE (UICC 2002)">pT1a</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">Follow-up = 148 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">none</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM55959"><item key="TUMOR STAGE (UICC 2002)">pT1b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 60 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">adrenal gland, renal, pancreas, parotis</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559592"><item key="TUMOR STAGE (UICC 2002)">pT3b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M1</item><item key="DFS/FOLLOW-UP">DFS = 0 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lung, mediastinal</item><item key="TUMOR GRADE">G3</item></item></item><item><item key="GSM559593"><item key="TUMOR STAGE (UICC 2002)">pT1b</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">Follow-up = 130 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">none</item><item key="TUMOR GRADE">G3</item></item></item><item><item key="GSM559594"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">Follow-up = 140 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">none</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559595"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 1 month</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">lung</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559596"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M1</item><item key="DFS/FOLLOW-UP">DFS = 0 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">skin</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559597"><item key="TUMOR STAGE (UICC 2002)">pT2</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M1</item><item key="DFS/FOLLOW-UP">DFS = 0 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lung</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559598"><item key="TUMOR STAGE (UICC 2002)">pT3a</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 0 months</item><item key="LYMPH NODE STATUS">N1</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lymph node</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559599"><item key="TUMOR STAGE (UICC 2002)">pT3a</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 82 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lung, skin</item><item key="TUMOR GRADE">G2</item></item></item><item><item key="GSM559600"><item key="TUMOR STAGE (UICC 2002)">pT3a</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">M0</item><item key="DFS/FOLLOW-UP">DFS = 90 months</item><item key="LYMPH NODE STATUS">N0</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">not specified</item><item key="TISSUE">primary clear-cell renal cell carcinoma</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">lung</item><item key="TUMOR GRADE">G3</item></item></item><item><item key="GSM559705"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">44</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 1 month</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559706"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">10</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 15 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559707"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">18</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 95 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559708"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">4</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 12 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559709"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">3</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 38 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559709"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">3</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 38 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM5597"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">16</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 10 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559712"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">24</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 2 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559713"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">1</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 9 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559714"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">3</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 31 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559715"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">24</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 1 month</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559716"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">37</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 1 month</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559717"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">1</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 60 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559718"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">6</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 156 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559719"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">8</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 90 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559719"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">8</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 90 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM55972"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">&gt;80</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 8 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559722"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">2</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 114 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559723"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">2</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 11 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559724"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">5</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 127 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559725"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 2 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Apr 2007</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">male</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559726"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 36 months</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Oct 2008</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559727"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 0 month</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Oct 2008</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item><item><item key="GSM559727"><item key="TUMOR STAGE (UICC 2002)">not specified</item><item key="NO. OF PULMONARY METASTASES">not specified</item><item key="INITIAL DISTANT METASTASES">not specified</item><item key="DFS/FOLLOW-UP">DFS = 0 month</item><item key="LYMPH NODE STATUS">not specified</item><item key="DATE OF SAMPLE PREPARATION AND HYBRIDISATION">Oct 2008</item><item key="TISSUE">pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)</item><item key="DISEASE FREE INTERVAL (DFI) IN MONTHS">not specified</item><item key="NO. OF METASTASES">not specified</item><item key="GENDER">female</item><item key="LOCALISATION OF METASTASES">not specified</item><item key="TUMOR GRADE">not specified</item></item></item></item><item key="id">3715</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">The understanding of metastatic spread is limited and molecular mechanisms causing particular characteristics of metastasis are largely...</item><item key="geo_gse_id">E-GEOD-22541</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">12</item><item key="sample_count">68</item><item key="tags"><item>carcinoma</item><item>cell</item><item>disease</item><item>organ</item><item>renal cell carcinoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">expression-data-from-pulmonary-metastases-and-prim</item><item key="geo_id_plat">E-GEOD-22541_A-AFFY-44</item><item key="name">Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals</item><item key="created">Sep.15, 2014</item><item key="summary">The understanding of metastatic spread is limited and molecular mechanisms causing particular characteristics of metastasis are largely unknown. This comprises the extremely varying dormancy periods of tumor cells in the secondary organ after metastatic spread, represented by the disease-free survival (DFS) of the patients, or differing numbers of metastases in different patients. Knowing the molecular fundamentals of these phenomena would support the individual prediction of patients&#180; outcome and facilitate the decision for an appropriate monitoring and therapy regime. In a first study (PMID 19391132) we analyzed the transcriptome-wide expression profiles of 20 pulmonary metastases of renal cell carcinoma (Met1-9, Met11-18, Met20, Met23, Met25) to identify expression patterns associated with the dormancy period and the number of metastases per patient. Pre-processed and analyzed data for this study are available in GEO Series GSE14378. In this second study, we validated the DFS-associated expression pattern from the first study on four further metastases and also included primary ccRCC with different DFS. For this, the microarray data of all metastases and primary tumors were pre-processed together. The aim of this second study was to identify those genes, which are differentially expressed in metastases developed after different dormancy periods and which are already deregulated in primary tumors. Genes differentially expressed in synchronously vs. metachronously metastases might contribute functionally to the dormancy period. Genes already deregulated in primary ccRCC might be suitable for prognostic purposes. metastases manifested synchronously or metachronously (DFS less than or equal to 9 months compared with DFS greater than or equal to 60 months); primary ccRCC which developed synchronous or metachronous metastases (DFS less than or equal to 6 months compared with DFS greater than or equal to 45 months)</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22541</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22541/samples/</item></data></biogps>
